EMAIL THIS PAGE TO A FRIEND

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.


PMID 26219596

Abstract

Recombinant tissue-type plasminogen activator (rt-PA) modulates cerebrovascular permeability and exacerbates brain injury in ischemic stroke, but its mechanisms remain unclear. We studied the involvement of vascular endothelial growth factor (VEGF)-mediated endocytosis in the increase of blood-brain barrier (BBB) permeability potentiated by rt-PA after ischemic stroke. The rt-PA treatment at 4 hours after middle cerebral artery occlusion induced a transient increase in BBB permeability after ischemic stroke in mice, which was suppressed by antagonists of either low-density lipoprotein receptor families (LDLRs) or VEGF receptor-2 (VEGFR-2). In immortalized bEnd.3 endothelial cells, rt-PA treatment upregulated VEGF expression and VEGFR-2 phosphorylation under ischemic conditions in an LDLR-dependent manner. In addition, rt-PA treatment increased endocytosis and transcellular transport in bEnd.3 monolayers under ischemic conditions, which were suppressed by the inhibition of LDLRs, VEGF, or VEGFR-2. The rt-PA treatment also increased the endocytosis of endothelial cells in the ischemic brain region after stroke in mice. These findings indicate that rt-PA increased BBB permeability via induction of VEGF, which at least partially mediates subsequent increase in endothelial endocytosis. Therefore, inhibition of VEGF induction may have beneficial effects after thrombolytic therapy with rt-PA treatment after stroke.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

M8904
6-Maleimidohexanoic acid, ≥98% (HPLC)
C10H13NO4
755842
6-Maleimidohexanoic acid, 90% (GC)
C10H13NO4
SAB4501785
Anti-CD91, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB2101380
Anti-LRP1 (ab1) antibody produced in rabbit, affinity isolated antibody
SAB2101381
Anti-LRP1 (ab2) antibody produced in rabbit, affinity isolated antibody
SAB1300081
Anti-LRP1 (C-term) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
L2295
Anti-LRP1 (N-terminal) antibody produced in rabbit, ~1.0 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB1400154
Anti-LRP1 antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
HPA022903
Anti-LRP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA004182
Anti-LRP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA002321
Anti-MVP antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2103654
Anti-MVP, (N-terminal) antibody produced in rabbit, affinity isolated antibody
SAB4300066
Anti-phospho-KDR (pTyr1175) antibody produced in rabbit, affinity isolated antibody
SAB4300067
Anti-phospho-KDR (pTyr1214) antibody produced in rabbit, affinity isolated antibody
SAB4300068
Anti-phospho-KDR (pTyr951) antibody produced in rabbit, affinity isolated antibody
SAB4300656
Anti-phospho-VEGFR2 (pTyr1059) antibody produced in rabbit, affinity isolated antibody
SAB4504007
Anti-phospho-VEGFR2 (pTyr1059) antibody produced in rabbit, affinity isolated antibody
SAB4504567
Anti-phospho-VEGFR2 (pTyr1175) antibody produced in rabbit, affinity isolated antibody
SAB4504568
Anti-phospho-VEGFR2 (pTyr1214) antibody produced in rabbit, affinity isolated antibody
SAB4504569
Anti-phospho-VEGFR2 (pTyr951) antibody produced in rabbit, affinity isolated antibody
AV45366
Anti-PTPRA antibody produced in rabbit, affinity isolated antibody
SAB4200319
Anti-PTPRA antibody produced in rabbit, ~1.0 mg/mL
HPA029412
Anti-PTPRA antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2701667
Anti-rpsa antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2701817
Anti-rpsa antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2103754
Anti-RPSA antibody produced in rabbit, affinity isolated antibody
SAB2107067
Anti-RPSA antibody produced in rabbit, affinity isolated antibody
SAB3501075
Anti-RPSA antibody produced in rabbit, affinity isolated antibody
L2420
Monoclonal Anti-LRP1 antibody produced in mouse, ~1.0 mg/mL, clone LRP1-11, purified immunoglobulin, buffered aqueous solution
M7192 Monoclonal Anti-Major Vault Protein antibody produced in mouse, 250 μg/mL, clone MVP-37, tissue culture supernatant